Display options
Share it on

Endocrinol Metab Clin North Am. 2020 Jun;49(2):275-287. doi: 10.1016/j.ecl.2020.02.006. Epub 2020 Apr 09.

Role of Commercial Weight-Loss Programs in Medical Management of Obesity.

Endocrinology and metabolism clinics of North America

Kimberly A Gudzune, Jeanne M Clark

Affiliations

  1. Department of Medicine, Johns Hopkins University School of Medicine, 2024 East Monument Street, Room 2-621, Baltimore, MD 21224, USA. Electronic address: [email protected].
  2. Department of Medicine, Johns Hopkins University School of Medicine, 2024 East Monument Street, Room 2-600, Baltimore, MD 21224, USA. Electronic address: https://twitter.com/jmclark_md.

PMID: 32418590 DOI: 10.1016/j.ecl.2020.02.006

Abstract

Rates of obesity counseling are low among physicians because of the lack of time and training in this area. In recognition of this challenge, recent national guidelines encourage physicians to refer patients with obesity to intensive, comprehensive lifestyle programs to lose weight. Some commercial weight-loss programs meet these criteria, and this article reviews the evidence from randomized controlled trials regarding such programs' weight-loss efficacy and safety as well as glycemic outcomes among patients with and without diabetes mellitus. A discussion of how physicians might approach the referral process and continued management of patients participating in these programs is included.

Copyright © 2020 Elsevier Inc. All rights reserved.

Keywords: Obesity; Treatment outcome; Weight reduction programs

Conflict of interest statement

Disclosure Dr K.A. Gudzune is a paid consultant for the American Board of Obesity Medicine and Eli Lilly. She is also supported by a grant from NIMH (P50MH115842). Dr J.M. Clark is supported by a gran

MeSH terms

Publication Types

Grant support